James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why Aduro BioTech Inc (ADRO), Brocade Communications Systems, Inc. (BRCD) and Delta Air Lines, Inc. (DAL) Are 3 of Today’s Worst Stocks

Aduro BioTech (ADRO), Brocade Communications Systems (BRCD) and Delta Air Lines (DAL) couldn't win for losing on Tuesday.

Why MannKind Corporation (MNKD), Electronic Arts Inc. (EA) and GameStop Corp. (GME) Are 3 of Today’s Worst Stocks

MannKind (MNKD), Electronic Arts (EA) and GameStop (GME) couldn't win for losing on Monday.

Market Underestimates Pfizer Stock After Allergan Deal

Pfizer stock has been falling on rumors, and then official reports, of a buyout of Allergan, but there's no real downside to this pairing.

Groupon CEO Rich Williams Just Doesn’t Get It (GRPN)

Sometimes the best thing a CEO can say is nothing. And, unlike Groupon CEO Rich Williams did to GRPN owners and analysts, if a CEO is going to speak, make sure it's not insulting.

HPQ Stock: What to Know Before Hewlett-Packard Reports Earnings

HPQ shares may be up since the company became two entities, but it's just too soon to be making judgment calls.